A Randomised, Double-blind, Double Dummy, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening All Administered by Inhalation Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.
Latest Information Update: 22 Aug 2023
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 21 Aug 2012 New trial record
- 12 Jul 2012 Results published in Clinical Therapeutics.